PPARG and autoimmune disease: Animal models of inflammatory bowel diseases displayed significantly reduced colonic inflammation with PUFA feeding48 and reduced severity of EAE after PUFA supplementation49, suggesting that PPARγ has a potential role in the treatment of autoimmune diseases.